首页> 美国卫生研究院文献>Environmental Health Perspectives >Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.
【2h】

Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.

机译:利福霉素衍生物的诱导和自诱导特性:动物和人类研究综述。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Animal studies have demonstrated that the mouse and rabbit are far more responsive to the inductive properties of rifamycin derivatives than the rat and guinea pig. The rat hepatic cytochrome P450 system seems to be resistant to the action of rifampicin unless very high doses are used. Mouse hepatic microsomal mixed-function oxidase activity is markedly increased by repeated dosing with rifampicin, whereas administration of rifabutin may be ineffective. In humans, both rifampicin and rifabutin are extensively metabolized and induce their own metabolism. The induced metabolic pathways remain essentially unknown. Under autoinduction conditions, the elimination half-life of rifampicin decreases, whereas that of rifabutin is not altered. Although the effects of repeated administration of rifampicin and rifabutin on the various forms of cytochrome P450 in humans have not been extensively examined, there is convincing evidence that the P4503A subfamily is induced by either drug, whereas the P4501A subfamily and P4502D6 do not appear to be affected by rifampicin. Limited reliable information is available concerning the induction of human glucuronyltransferase activities by rifampicin and rifabutin which, however, do not seem to influence zidovudine glucuronide formation in healthy subjects.
机译:动物研究表明,与大鼠和豚鼠相比,小鼠和兔子对利福霉素衍生物的诱导特性反应要强得多。除非使用非常高的剂量,否则大鼠肝细胞色素P450系统似乎对利福平的作用具有抗性。重复使用利福平可明显增加小鼠肝微粒体混合功能氧化酶的活性,而利福布汀的给药可能无效。在人类中,利福平和利福布汀均被广泛代谢并诱导自身代谢。诱导的代谢途径基本上仍然未知。在自动诱导条件下,利福平的消除半衰期降低,而利福布汀的消除半衰期不变。尽管尚未广泛研究过反复施用利福平和利福布丁对人类各种形式的细胞色素P450的影响,但令人信服的证据表明,P4503A亚家族是由任一药物诱导的,而P4501A亚家族和P4502D6似乎不是受利福平影响。关于利福平和利福布汀诱导人葡糖醛酸转移酶活性的可靠信息有限,但是似乎并不影响健康受试者中齐多夫定葡糖醛酸苷的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号